LINC01126: A Drug Target / Disease Biomarker (G100129726)

Target Name: LINC01126

NCBI ID: G100129726

LINC01126

Other Name(s): Long intergenic non-protein coding RNA 1126 | long intergenic non-protein coding RNA 1126

LINC01126: A Drug Target / Disease Biomarker

LINC01126 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the blood-brain barrier, which is a specialized barrier that separates the brain from the surrounding blood vessels and ensures the delivery of essential nutrients and oxygen while preventing harmful substances from entering the brain.

The blood-brain barrier is a critical structure that serves as a barrier between the brain and the bloodstream. It is made up of endothelial cells, which are specialized cells that line the blood vessels and the brain, and it is designed to keep harmful substances out of the brain. The blood-brain barrier is constantly monitored by the immune system, and any changes in its structure or function can have serious consequences for brain health.

LINC01126 is a protein that is expressed in the brain and is involved in the regulation of the blood-brain barrier. It is a key regulator of the tight junction, which is the structure that connects the endothelial cells of the blood-brain barrier. The tight junction helps to maintain the integrity of the blood-brain barrier by controlling the movement of cells and molecules into and out of the brain.

In addition to its role in regulating the blood-brain barrier, LINC01126 is also involved in the regulation of cell signaling pathways that are important for brain development and function. It has been shown to play a role in the regulation of neurogenesis, which is the process by which new neurons are produced in the brain.

LINC01126 is also involved in the regulation of the immune response, which is an important part of brain health. The immune response is necessary for the brain to fight off infections and other harmful substances that could cause damage to the brain.

In addition to its role in the immune response, LINC01126 is also involved in the regulation of the cell cycle. The cell cycle is the process by which cells grow, divide, and replicate themselves. LINC01126 is involved in the regulation of the cell cycle by controlling the movement of chromosomes into and out of the nucleus.

In conclusion, LINC01126 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of the blood-brain barrier, cell signaling pathways, and the immune response. It is also involved in the regulation of the cell cycle. As a potential drug target, LINC01126 is a promising target for the development of new treatments for a variety of brain health conditions.

Protein Name: Long Intergenic Non-protein Coding RNA 1126

The "LINC01126 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01126 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets